50.08 
0.10(0.20%) May 21, 4:03PM EDT|After Hours
:
50.02 0.06 (0.12%) May 21, 4:11PM EDT
| Prev Close: | 49.98 |
|---|
| Open: | 49.76 |
|---|
| Bid: | 44.09 x 100 |
|---|
| Ask: | 60.00 x 100 |
|---|
| 1y Target Est: | 47.36 |
|---|
| Beta: | 0.82 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 49.59 - 50.23 |
|---|
| 52wk Range: | 29.82 - 51.40 |
|---|
| Volume: | 540,694 |
|---|
| Avg Vol (3m): | 1,037,080 |
|---|
| Market Cap: | 7.13B |
|---|
| P/E (ttm): | 23.48 |
|---|
| EPS (ttm): | 2.13 |
|---|
| Div & Yield: | 0.68 (1.40%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- One Year After The IPO, Is Facebook Already Becoming A New Economy Dog?at Forbes(Sun, May 19)
- 4 Stocks Going Ex-Dividend Tomorrow: SLH, STO, RMD, RCLat TheStreet(Thu, May 16)
- ResMed Stock To Go Ex-dividend Tomorrow (RMD)at TheStreet(Thu, May 16)
- FMS, COO, RMD, THC And HCA, Pushing Health Services Industry Downwardat TheStreet(Wed, May 15)
- ResMed (RMD) Goes Ex-Dividend Soonat Forbes(Wed, May 15)
- X Factor: 5 Stocks Reaching Their Ex-Dividend Date on May 17at Minyanville(Fri, May 10)
- Cashed-Up ResMed Mulls $1 Billion Questionat The Wall Street Journal(Thu, May 9)
- ResMed Stock Hits New 52-Week High (RMD)at TheStreet(Wed, May 8)
- New Stock Picks From Navellier & Associatesat Seeking Alpha(Tue, May 7)
- RESMED INC FinancialsEDGAR Online Financials(Tue, May 7)
- Got Growth? These 5 Stocks Doat Seeking Alpha(Tue, May 7)
- 1 Tech, 1 Healthcare And 1 Industrial Goods Company With Recent Intensive Insider Sellingat Seeking Alpha(Mon, May 6)
- RESMED INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Tue, Apr 30)
- ResMed's Earnings Beat; Revs LagZacks(Mon, Apr 29)
- ResMed Management Discusses Q3 2013 Results - Earnings Call Transcriptat Seeking Alpha(Thu, Apr 25)
Key Statistics
| Forward P/E (1 yr): | 20.44 |
|---|
| P/S (ttm): | 4.84 |
|---|
| Ex-Dividend Date: | 17-May-13 |
|---|
Analysts
| Annual EPS Est
(Jun-13)
: | 2.25 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.61 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 1.44 |
|---|
Business Summary
ResMed Inc., through its subsidiaries, engages in the development, manufacture, and distribution of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders.
View More